Explainable ai in microbiome diagnostics

Introduction

Explainable artificial intelligence (XAI) in microbiome diagnostics refers to the use of AI technologies that can provide understandable explanations for diagnostic predictions generated through the analysis of microorganisms present in the human body.

The human microbiome consists of bacteria, viruses, fungi and other microorganisms living in different parts of the body, including the digestive tract, skin and respiratory system. Changes in microbial composition may be associated with diseases, infections, metabolic disorders and immune-system conditions.

Modern microbiome diagnostics use machine learning, genomic sequencing and computational biology to identify microbial patterns associated with particular health conditions. However, complex AI models may generate diagnostic predictions without clearly explaining how they reached their conclusions. Explainable AI addresses this problem by making diagnostic processes more transparent, scientifically verifiable and accountable.

Meaning and objectives of explainable AI

Explainable AI refers to techniques that make the decisions and predictions of artificial intelligence systems understandable to human users.

In microbiome diagnostics, an AI system may analyse microbial sequencing data and predict whether a patient has a particular gastrointestinal disorder. Explainability helps doctors and researchers understand which microbial characteristics influenced that prediction.

The principal objectives include:

Improving transparency in microbiome-based diagnosis.

Identifying errors in microbial data interpretation.

Reducing algorithmic bias.

Supporting clinical decision-making.

Protecting sensitive genetic and medical information.

Establishing accountability for incorrect diagnostic predictions.

Improving confidence in AI-assisted healthcare technologies.

Explainability is particularly important because the presence of a microorganism does not automatically establish the existence or cause of a disease.

Legal framework in India

1. Article 21 of the Constitution

Article 21 protects life and personal liberty. Judicial interpretation has expanded its scope to include privacy, dignity and personal autonomy.

Microbiome diagnostics may involve sensitive biological and medical information. Therefore, AI-based diagnostic systems must respect constitutional privacy protections and applicable healthcare safeguards.

2. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023, regulates the processing of digital personal data.

Microbiome diagnostic platforms may process identifiable health information, biological research records and genetic information. Where such information falls within the Act's scope, applicable requirements concerning lawful processing, security safeguards and individual rights must be followed.

However, the Act does not establish a comprehensive standalone right to receive an explanation of every AI-generated diagnostic decision. Its application must also be considered alongside commencement notifications and applicable rules.

3. Medical Devices Rules, 2017

Microbiome diagnostic products involving AI-based software may fall within the Medical Devices Rules, 2017, depending on their intended medical purpose and classification.

Such products may be subject to applicable requirements concerning licensing, safety, performance, quality management and regulatory oversight.

4. Information Technology Act, 2000

The Information Technology Act, 2000, provides a framework addressing electronic records and specified cyber-related offences.

Microbiome diagnostic platforms often rely on cloud databases, genomic sequencing records and digital laboratory systems. Appropriate cybersecurity and protection against unauthorised access are therefore important.

5. ICMR ethical guidelines

The ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017, establish important ethical principles for biomedical research.

They emphasise informed consent, confidentiality, participant protection and independent ethical review. These principles are relevant when microbiome datasets are collected or used for AI-based diagnostic research.

Major explainability requirements

1. Transparency of diagnostic algorithms

Developers should provide meaningful information about the functioning, purpose and limitations of microbiome diagnostic AI systems.

Relevant information may include the model's training methods, microbial features examined, validation procedures and intended clinical applications.

2. Explanation of microbial biomarkers

AI systems should identify the microbial patterns or biological indicators that significantly influence a diagnostic prediction.

For example, a system predicting an increased likelihood of a gastrointestinal disorder should explain which microbial characteristics contributed to its conclusion.

However, researchers must distinguish between statistical associations and scientifically established disease-causing relationships.

3. Data quality and reliability

Microbiome datasets may vary according to sample collection methods, sequencing technologies, laboratory conditions and geographical populations.

Explainable systems should provide information about these limitations so that healthcare professionals can understand the reliability of the results.

4. Algorithmic bias prevention

AI models trained primarily on microbiome data from limited populations may produce inaccurate predictions for other demographic or geographical groups.

Developers should conduct independent validation and evaluate whether the diagnostic model performs consistently across relevant populations.

5. Human supervision

AI-generated diagnostic predictions should support clinical professionals rather than automatically replace medical judgment.

Doctors should be able to examine the underlying evidence, question uncertain predictions and consider other diagnostic information before making treatment decisions.

Important case laws

1. Justice K.S. Puttaswamy v. Union of India (2017)

The Supreme Court recognised privacy as a fundamental right under Article 21 and other constitutional guarantees.

The judgment is relevant to microbiome diagnostics because biological and health datasets may reveal intimate information about individuals. It supports safeguards concerning privacy, lawful processing and protection against unnecessary disclosure.

2. Samira Kohli v. Dr. Prabha Manchanda (2008)

The Supreme Court explained the importance of informed consent in medical treatment. The judgment is relevant when patients undergo microbiome-based diagnostic procedures or participate in research involving AI-based interpretation of their biological samples.

Patients should receive appropriate information about the nature and purpose of medical procedures.

3. Jacob Mathew v. State of Punjab (2005)

The Supreme Court examined the legal principles governing medical negligence and professional standards. Its reasoning is relevant where healthcare professionals rely on AI-generated diagnostic recommendations. Medical decisions must be evaluated against applicable professional standards rather than assuming that an AI-generated result is automatically correct.

4. Indian Medical Association v. V.P. Shantha (1995)

The Supreme Court examined the application of consumer protection law to medical services. The judgment is relevant to disputes involving deficient healthcare services and potentially unreliable diagnostic technologies, subject to the circumstances of the case.

5. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court emphasised the importance of scientific expertise in evaluating complex technical and scientific questions. Although the case concerned environmental regulation, its reasoning is relevant by analogy when courts examine the scientific reliability of microbiome diagnostic algorithms.

These judgments do not directly establish specific explainability obligations for microbiome diagnostic AI. They provide broader principles concerning privacy, informed consent, medical accountability and scientific evaluation.

Challenges in implementing explainable AI

Microbiome diagnostics present several scientific and technical difficulties because microbial communities are complex and vary significantly between individuals.

Major challenges include:

Difficulty interpreting complex machine-learning models.

Variations in microbiome composition between populations.

Incomplete or inconsistent sequencing datasets.

False-positive and false-negative diagnostic predictions.

Difficulty distinguishing microbial associations from causation.

Lack of standardised diagnostic validation procedures.

Protection of confidential biological information.

Limited understanding of certain microbial interactions.

Another concern is overdependence on algorithmic predictions. A microbiome-based AI result should not independently establish a medical diagnosis without appropriate clinical evaluation.

Safeguards for responsible microbiome diagnostics

An effective regulatory framework should combine technical transparency, scientific validation and medical supervision.

Important safeguards include:

Maintaining documentation of training datasets and model architecture.

Conducting independent clinical validation.

Explaining important microbial indicators influencing predictions.

Testing diagnostic accuracy across different populations.

Protecting identifiable biological and medical information.

Disclosing limitations and uncertainty in diagnostic reports.

Maintaining human review of significant medical decisions.

Establishing accountability for manufacturers and healthcare providers.

Conclusion

Explainable AI in microbiome diagnostics is essential for improving the transparency, reliability and accountability of AI-assisted healthcare. India's constitutional privacy framework, the Digital Personal Data Protection Act, 2023, Medical Devices Rules, 2017, and ICMR ethical guidelines provide relevant legal and ethical foundations. Judicial decisions such as Justice K.S. Puttaswamy v. Union of India, Samira Kohli v. Dr. Prabha Manchanda and Jacob Mathew v. State of Punjab reinforce the importance of privacy, informed consent and medical responsibility. A responsible framework must combine understandable diagnostic predictions, independent scientific validation, secure biological-data management and meaningful human supervision.